Osteoporosis International

, Volume 27, Issue 4, pp 1675–1676 | Cite as

Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?

  • T. SugiyamaEmail author
  • K. Watarai
  • T. Oda
  • Y. T. Kim
  • H. Oda


Compliance with ethical standards

Conflict of interest



  1. 1.
    Zhou B, Huang Y, Li H, Sun W, Liu J (2016) Proton-pump inhibitors and risk of fractures: an update meta-analysis. Osteoporos Int 27:339–347. doi: 10.1007/s00198-015-3365-x CrossRefPubMedGoogle Scholar
  2. 2.
    Sugiyama T, Torio T, Miyajima T, Kim YT, Oda H (2016) Calcium, proton pump inhibitors, and fracture risk. Osteoporos Int 27:349–350. doi: 10.1007/s00198-015-3403-8 CrossRefPubMedGoogle Scholar
  3. 3.
    Zhou B, Huang Y, Li H, Sun W, Liu J (2015) Proton pump inhibitors and fracture risk: response to comments. Osteoporos Int. doi: 10.1007/s00198-015-3434-1 PubMedCentralGoogle Scholar
  4. 4.
    Lau AN, Tomizza M, Wong-Pack M, Papaioannou A, Adachi JD (2015) The relationship between long-term proton pump inhibitor therapy and skeletal frailty. Endocrine 49:606–610CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Schoenfeld AJ, Grady D (2016) Adverse effects associated with proton pump inhibitors. JAMA Intern Med. doi: 10.1001/jamainternmed.2015.7927 Google Scholar
  6. 6.
    Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME (2016) Proton pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. doi: 10.1001/jamainternmed.2015.7193 PubMedCentralGoogle Scholar
  7. 7.
    Bucur RC, Panjwani DD, Turner L, Rader T, West SL, Jamal SA (2015) Low bone mineral density and fractures in stages 3–5 CKD: an updated systematic review and meta-analysis. Osteoporos Int 26:449–458CrossRefPubMedGoogle Scholar
  8. 8.
    Cheungpasitporn W, Thongprayoon C, Kittanamongkolchai W, Srivali N, Edmonds PJ, Ungprasert P, O’Corragain OA, Korpaisarn S, Erickson SB (2015) Proton pump inhibitors linked to hypomagnesemia: a systematic review and meta-analysis of observational studies. Ren Fail 37:1237–1241CrossRefPubMedGoogle Scholar
  9. 9.
    de Baaij JH, Hoenderop JG, Bindels RJ (2015) Magnesium in man: implications for health and disease. Physiol Rev 95:1–46CrossRefPubMedGoogle Scholar
  10. 10.
    Uzoigwe OF (2016) Proton pump inhibitors and fracture: they do what it says on the tin? Osteoporos Int. doi: 10.1007/s00198-016-3497-7
  11. 11.
    Feng S, Luo Z, Liu D (2015) Efficacy and safety of odanacatib treatment for patients with osteoporosis: a meta-analysis. J Bone Miner Metab 33:448–454CrossRefPubMedGoogle Scholar
  12. 12.
    Duong LT, Leung AT, Langdahl B (2015) Cathepsin K inhibition: a new mechanism for the treatment of osteoporosis. Calcif Tissue Int. doi: 10.1007/s00223-015-0051-0 Google Scholar
  13. 13.
    Solomon DH, Diem SJ, Ruppert K, Lian YJ, Liu CC, Wohlfart A, Greendale GA, Finkelstein JS (2015) Bone mineral density changes among women initiating proton pump inhibitors or H2 receptor antagonists: a SWAN cohort study. J Bone Miner Res 30:232–239CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Jung SB, Nagaraja V, Kapur A, Eslick GD (2015) Association between vitamin B12 deficiency and long-term use of acid-lowering agents: a systematic review and meta-analysis. Intern Med J 45:409–416CrossRefPubMedGoogle Scholar
  15. 15.
    Bailey RL, van Wijngaarden JP (2015) The role of B-vitamins in bone health and disease in older adults. Curr Osteoporos Rep 13:256–261CrossRefPubMedGoogle Scholar
  16. 16.
    Sugiyama T, Kim YT, Oda H (2016) Skeletal adaptation to mechanical strain: a key role in osteoporosis. In: Shimada Y, Miyakoshi N (eds) Osteoporosis in orthopedics: assessment and therapeutic options. Springer, Tokyo, pp 3–22CrossRefGoogle Scholar
  17. 17.
    Sugiyama T, Torio T, Sato T, Matsumoto M, Kim YT, Oda H (2015) Improvement of skeletal fragility by teriparatide in adult osteoporosis patients: a novel mechanostat-based hypothesis for bone quality. Front Endocrinol 6:6Google Scholar
  18. 18.
    Sugiyama T, Kono Y, Sekiguchi K, Kim YT, Oda H (2015) Age-related fragility fracture: insights from the natural homeostatic system in the skeleton. Arch Osteoporos 10:45CrossRefPubMedGoogle Scholar
  19. 19.
    Saito M, Marumo K (2016) Collagen cross-links as a determinant of bone quality. In: Shimada Y, Miyakoshi N (eds) Osteoporosis in orthopedics: assessment and therapeutic options. Springer, Tokyo, pp 35–54CrossRefGoogle Scholar
  20. 20.
    Thaler HW, Sterke CS, van der Cammen TJ (2016) Association of proton pump inhibitor use with recurrent falls and risk of fractures in older women: a study of medication use in older fallers. J Nutr Health Aging 20:77–81CrossRefPubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2016

Authors and Affiliations

  • T. Sugiyama
    • 1
    Email author
  • K. Watarai
    • 1
  • T. Oda
    • 1
  • Y. T. Kim
    • 1
  • H. Oda
    • 1
  1. 1.Department of Orthopaedic SurgerySaitama Medical UniversitySaitamaJapan

Personalised recommendations